Treatment of Acute Lymphoblastic Leukemia HIGH RISK BCR / ABL NEGATIVE IN ADULTS

NCT01540812 · clinicaltrials.gov ↗

COMPLETED

Status

418

Enrollment

OTHER

Sponsor class

Conditions

Acute Lymphoblastic Leukemia

Interventions

DRUG: Vincristine in induction
DRUG: Daunorubicin in induction
DRUG: Prednisone in induction
DRUG: Metotrexato in induction
DRUG: Cytarabine in induction
DRUG: Hydrocortisone in induction
DRUG: Idarubicin in induction-2
DRUG: Fludarabine in induction-2
DRUG: Ara-C in induction-2
DRUG: G-CSF in induction-2
DRUG: Dexamethasone in consolidation-1
DRUG: Vincristrine in consolidation-1
DRUG: Metotrexato in consolidation-1
DRUG: PEG-ASP in consolidation-1
DRUG: Dexamethasone in consolidation-2
DRUG: ARA-C in consolidation-2
DRUG: PEG-ASP in consolidation-2
DRUG: Dexamethasone in consolidation-3
DRUG: Vincristine in consolidation-3
DRUG: Metotrexato in consolidation-3

Sponsor

PETHEMA Foundation